An updated edition of the February 3, 2026 article.A rising aging population is becoming one of the most powerful long-term investment themes in healthcare. While many investors focus on pharmaceutical companies, biotech firms and medical device makers, another segment is quietly benefiting from the same demographic shift — healthcare real estate and senior care services. As the global population aged 60 and above continues to grow over the next decade, demand is rising not just for medical treatments but a ...

VANCOUVER, British Columbia & TORONTO--(BUSINESS WIRE)--WELL Health Technologies Corp. (TSX: WELL) (the "Company†or "WELL†), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, today expressed its strong support for the Ontario government's announcement of a new provincewide Primary Care Medical Record system, and confirmed its intent to actively participate in the forthcoming pro. ...

Core Viewpoint - The valuation of Welltower (WELL) is excessively high for a REIT, trading at 39X forward AFFO, 43.7X EV/EBITDA, and 205% of net asset value, which is not justifiable given its growth metrics [1][2]. Group 1: Valuation Metrics - Welltower's current valuation metrics include a P/LTM FFO of 75.99, P/NTM FFO of 33.28, P/NTM AFFO of 38.89, and a Debt/EBITDA ratio of 4.85 [2]. - The company is trading at 205.09% of its net asset value, indicating a significant premium over its intrinsic value [2]. Group 2: Growth Analysis - Welltower's growth rate is within the normal range for REITs, with a projected AFFO growth from $2.84 in 2022 to an estimated $5.32 in 2026 [4]. - The company's earnings have only slightly improved since 2015, with a 10-year growth rate of approximately 2% CAGR, suggesting that recent growth is primarily a recovery from prior sector downturns [8][9]. Group 3: Management and Market Perception - The market attributes Welltower's stock performance to its management, particularly CEO Shankh Mitra, who took over during a low point for REITs [15][17]. - The perception of Welltower as a superior company is challenged, as its performance aligns more closely with industry peers rather than indicating exceptional management capabilities [22][46]. Group 4: Capital Raising and Investment Strategy - Welltower has effectively utilized its high valuation to issue equity, raising significant capital at a low cost of 2.6%, which can be used for property acquisitions [36][40]. - The company has developed an AI-driven capital allocation engine to enhance its investment efficiency, although skepticism remains regarding its effectiveness in property selection [41]. Group 5: Compensation and Financial Implications - CEO Shankh Mitra's compensation has escalated significantly, reaching $20.8 million in 2024, which could impact overall earnings [46]. - The company's high valuation and management compensation structure raise concerns about long-term sustainability and shareholder value [47].

Core Viewpoint - Welltower's recent earnings report shows strong performance with significant year-over-year growth in both FFO and revenues, indicating potential for continued positive momentum leading up to the next earnings release [3][4][8]. Financial Performance - Welltower's Q4 2025 normalized FFO per share was $1.45, exceeding the Zacks Consensus Estimate of $1.44, and reflecting a 28.3% increase year over year [3]. - The company reported revenues of $3.18 billion for the quarter, surpassing the Zacks Consensus Estimate of $2.71 billion, marking a 41.3% year-over-year increase [4]. - The same-store revenues in the SHO portfolio increased by 9.6% year over year, supported by a 400 basis-point rise in average occupancy and a 4.7% growth in Revenue per Occupied Room (RevPOR) [5]. Investment and Dispositions - In Q4, Welltower's pro-rata gross investments totaled $13.9 billion, which included $1.2 billion in loan funding and $112 million in development funding [6]. - The company completed pro-rata property dispositions of $6.1 billion and loan repayments of $1.4 billion during the same quarter [6]. Balance Sheet Position - As of December 31, 2025, Welltower had $10.2 billion in available liquidity, consisting of $5.2 billion in cash and restricted cash, along with full capacity under its $5 billion line of credit [7]. 2026 Guidance - Welltower provided guidance for 2026 normalized FFO per share in the range of $6.09 to $6.25, anticipating average blended SSNOI growth of 11.25% to 15.75% across various segments [8]. - The company plans to fund an additional $370 million in development for ongoing projects in 2026 [8]. Market Sentiment - There has been an upward trend in estimates for Welltower over the past month, indicating positive market sentiment [9]. - Welltower currently holds a Zacks Rank of 3 (Hold), suggesting an expectation of in-line returns in the coming months [12]. Industry Comparison - Welltower operates within the Zacks REIT and Equity Trust - Other industry, where competitor Healthpeak (DOC) has seen a 0.7% gain over the past month, with its recent revenue growth at 3.1% year over year [13].

Core Viewpoint - Welltower Inc. has successfully amended and upsized its senior unsecured revolving line of credit to $6.25 billion, enhancing its debt maturity profile and reducing costs while improving financial flexibility [1] Group 1: Financial Details - The amended revolving facility includes a $4.25 billion tranche maturing on March 6, 2030, and a $2.0 billion tranche maturing on July 24, 2029, with options for extension [1] - The loans under the facility bear interest at 67.5 basis points over SOFR and an annual facility fee of 12.5 basis points [1] - The total available credit facilities for the company have increased to approximately $7.5 billion following this amendment [1] Group 2: Credit Rating and Financial Strategy - Moody's has revised Welltower's credit rating outlook from stable to positive, citing improvements in key credit metrics and a focus on organic growth and equity-funded investments [1] - The company aims to deliver long-term compounding of per share growth for investors through disciplined capital allocation and a strong operational framework [1] Group 3: Management Commentary - The Co-President and CFO of Welltower emphasized that the upsizing and extension of the line of credit strengthens the balance sheet and lowers the cost of capital, positioning the company well for future growth [1] - The support from a diverse group of financial institutions in the refinancing process was acknowledged as a key factor in enhancing liquidity and maintaining low leverage [1]

Core Insights - Welltower's shares have increased by 10% year-to-date, outperforming the industry average of 7.4% [1][7] Company Overview - Welltower is a healthcare real estate investment trust (REIT) with a diversified portfolio of healthcare real estate assets across the United States, Canada, and the UK [2] - The aging population and rising healthcare expenditures among senior citizens position Welltower's seniors housing operating portfolio (SHOP) for solid demand [2][3] Market Dynamics - The national healthcare expenditure by senior citizens is expected to rise, benefiting Welltower as this demographic incurs higher healthcare costs [3] - A muted new supply in the senior housing market serves as a tailwind for the industry, allowing Welltower's SHOP to capitalize on favorable trends [3][4] Strategic Initiatives - Welltower is focused on enhancing its SHOP through strategic property additions and capital recycling, which has improved operator diversification and expanded its geographic presence in high-demand urban markets [4][5] - In 2025, Welltower completed $19.74 billion in pro-rata gross investments, including $19.28 billion in acquisitions and loan funding, alongside $6.53 billion in property dispositions [5][7] Financial Position - As of December 31, 2025, Welltower had $10.2 billion in available liquidity, including $5.2 billion in cash and a fully utilized $5 billion line of credit [8] - The company's net debt to adjusted EBITDA ratio was 3.03X, with a well-laddered debt maturity profile averaging 5.5 years, enhancing financial flexibility [8] Future Outlook - Given the positive factors, the upward trend in Welltower's stock price is expected to continue in the near term [9]

Core Insights - Welltower is recognized as a strong REIT, but high valuations can lead to poor investment outcomes [1] - The focus is on identifying undervalued REITs that provide the best risk-to-reward ratio, which has led to consistent market outperformance [1] - Current recommendations include top picks for 2026, highlighting REITs that are trading at significant discounts to their property values and offering higher yields [1]

Core Insights - Real estate investment trusts (REITs) are required to pay out 90% of their taxable income as dividends, leading to attractive dividend yields [1] - REITs vary in focus, including residential and entertainment properties, but must provide reliable dividends for investors [2] Company Analysis: Medical Properties Trust (MPT) - Medical Properties Trust is a healthcare REIT with a current dividend yield of 5.7% [3] - The quarterly dividend is $0.09 per share, totaling $0.36 annually, which has seen a slight increase despite a declining trend [5] - The stock has dropped 74% over the past five years, contributing to the high yield [5] - In 2025, Medical Properties Trust reported a loss of $276 million, an improvement from a $2.4 billion loss in 2024, but still indicates ongoing financial struggles [7] - Funds from operations (FFO) for 2025 were $346.2 million, down nearly 29% year-over-year, with a significant debt load of $9.6 billion against $540.8 million in cash [8] Company Analysis: Welltower Inc. - Welltower is a medical REIT focusing on medical office space and senior living facilities [10] - The company has a market cap of $143 billion and owns over 2,500 senior and wellness housing communities [12] - In 2025, Welltower's total revenue grew by 35% to $10.8 billion, with a slight decline in net income from $972.8 million to $961.8 million [13] - Annual normalized FFO attributable to common stockholders was $5.29 per diluted share, reflecting a 22.5% increase over 2024 [14] - Welltower pays a quarterly dividend of $0.74, yielding 1.44%, which is lower than Medical Properties Trust but considered safer [15] - The payout ratio is currently 189%, which is high but has improved from previous years [16] - The growing 80+ population in the U.S. is expected to drive further growth for Welltower [17]

Core Viewpoint - Despite the S&P 500's stagnation and rising market anxiety, certain companies are thriving due to their immunity to tariff impacts and strong operational fundamentals [1]. Group 1: Waste Management (NYSE:WM) - Waste Management operates without international revenue, making it immune to tariff fluctuations, and reported a 2025 revenue of $25.204 billion, a 14.24% increase year-over-year [2]. - The company achieved a 30% adjusted EBITDA margin for the first time, with core pricing growth of 6.3% in 2025 [2]. - Free cash flow is expected to grow nearly 30% in 2026, supported by investments in recycling and renewable energy [2]. - The stock is up 12% year-to-date, trading at approximately 30x forward earnings, with a target price of $253 [2]. Group 2: Republic Services (NYSE:RSG) - Republic Services, the second-largest waste hauler in the U.S., mirrors Waste Management's tariff immunity and has a strong pricing power [3]. - The company reported a 16.91% increase in free cash flow to $2.433 billion for 2025, with a revenue guidance of $17.05 to $17.15 billion for 2026 [4]. - Core pricing growth was 5.9% for 2025, and the company returned $1.6 billion to shareholders through dividends and buybacks [4]. - The stock is up 9.6% year-to-date, trading at about 32x trailing earnings, with a consensus target of $244 [5]. Group 3: Welltower (NYSE:WELL) - Welltower operates in the senior housing sector, which is not affected by tariffs, generating revenue from occupancy rates and healthcare rents [6]. - The company reported a 20.4% year-over-year growth in same-store NOI for 2025, with occupancy rates reaching 89.5% [7]. - Normalized FFO guidance for 2026 is between $6.09 and $6.25 per share, and the quarterly dividend was raised by 10.4% [7]. - The stock is up nearly 11% year-to-date and has increased 34.6% over the past year, with a target price of $227.50 [8]. Group 4: WEC Energy Group (NYSE:WEC) - WEC Energy Group operates regulated utilities, providing a tariff-proof business model with state-approved rates [9]. - The company reported an adjusted EPS of $5.27 for 2025, an 8% increase year-over-year, and guided for 2026 EPS of $5.51 to $5.61 [11]. - The dividend has grown for 23 consecutive years, currently yielding about 3%, with retail electricity deliveries up 2.2% in 2025 [11]. - The stock is up 11% year-to-date, nearing its 52-week high of $117.60 [12]. Group 5: Visa (NYSE:V) - Visa operates a business model that is unaffected by tariffs, generating revenue from electronic transactions rather than physical goods [13]. - The company reported Q1 fiscal 2026 revenue of $10.9 billion, a 14.6% year-over-year increase, with processed transactions rising by 9% to 69.4 billion [14]. - Despite being down about 8.6% year-to-date, Visa has a consensus target price of $400 compared to its current price near $320 [14]. Common Thread - Four of the five highlighted stocks are outperforming the S&P 500 by double digits in 2026, indicating a shift in Wall Street's focus towards businesses less affected by trade policy uncertainties [15].

Core Insights - Welltower Inc. is a leading healthcare real estate investment trust (REIT) with a market cap of $146.6 billion, focusing on properties serving the healthcare industry in the U.S., Canada, and the U.K. [1] - The company benefits from long-term demographic trends, including aging populations and increasing demand for healthcare services, by partnering with top healthcare systems and operators [2] Company Performance - Welltower's stock reached a 52-week high of $216.43 on February 17 and is currently trading 3.9% below that peak, with shares having increased by 3% over the past three months [3] - Over the past six months, Welltower's stock has risen by 24.2% and by 32.6% over the past 52 weeks, significantly outperforming the Real Estate Select Sector SPDR Fund (XLRE), which saw a 5.4% increase during the same period [4] - The stock has consistently traded above its 200-day moving average over the past year, indicating a bullish trend [4] Financial Highlights - In Q4 FY2025, Welltower reported revenue of approximately $3.18 billion and normalized funds from operations of $1.45 per share, showing strong year-over-year growth [5] - The company's same-store revenue in its senior housing operating portfolio increased by 9.6%, with occupancy rising by about 400 basis points [5] - Welltower completed $13.9 billion in investments and $7.5 billion in dispositions and loan repayments during the quarter, reflecting active portfolio repositioning [5]